Immunogen (IMGN) CEO Buys 25K Shares

November 9, 2016 1:37 PM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Immunogen (NASDAQ: IMGN) CEO, Mark Enyedy, bought 25,000 shares on 11/08 at $1.83.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insider Trades

Add Your Comment